Twist Bioscience to Report Fiscal 2021 Third Quarter Financial Results on Friday, August 6, 2021
21 July 2021 - 10:00PM
Business Wire
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling
customers to succeed through its offering of high-quality synthetic
DNA using its silicon platform, today announced that it will issue
its financial results for the fiscal 2021 third quarter ended June
30, 2021, before market open on Friday, August 6, 2021. The company
plans to hold a conference call and live audio webcast for analysts
and investors at 8:00 a.m. Eastern Time to discuss its financial
results and provide an update on the company’s business. The press
release with the financial results will be accessible from the
company’s website prior to the conference call through the Investor
Relations section under the “Company” tab at
www.twistbioscience.com.
The call can be accessed by dialing (866) 688-0947 (domestic) or
(409) 217-8781 (international) and refer to the conference ID
3485949. A telephonic replay of the conference call will be
available beginning approximately four hours after the call through
August 13, 2021 and may be accessed by dialing (855) 859-2056
(domestic) or (404) 537-3406 (international). The replay conference
ID is 3485949. The webcast replay will be available for two
weeks.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic
biology and genomics company that has developed a disruptive DNA
synthesis platform to industrialize the engineering of biology. The
core of the platform is a proprietary technology that pioneers a
new method of manufacturing synthetic DNA by “writing” DNA on a
silicon chip. Twist is leveraging its unique technology to
manufacture a broad range of synthetic DNA-based products,
including synthetic genes, tools for next-generation sequencing
(NGS) preparation, and antibody libraries for drug discovery and
development. Twist is also pursuing longer-term opportunities in
digital data storage in DNA and biologics drug discovery. Twist
makes products for use across many industries including healthcare,
industrial chemicals, agriculture and academic research.
Follow us on Twitter | Facebook | LinkedIn | YouTube
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210721005313/en/
Angela Bitting SVP, Corporate Affairs 925-202-6211
abitting@twistbioscience.com
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Jun 2024 to Jul 2024
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Jul 2023 to Jul 2024